| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003809691 |
| P356 | DOI | 10.1186/AR2133 |
| P932 | PMC publication ID | 1906797 |
| P698 | PubMed publication ID | 17335569 |
| P5875 | ResearchGate publication ID | 6470365 |
| P2093 | author name string | Alain Cantagrel | |
| Arnaud Constantin | |||
| Bernard Pipy | |||
| Bernard Mazières | |||
| Jean-Luc Davignon | |||
| José Bernad | |||
| Hélène Authier | |||
| Bruno Faucon | |||
| Jean Frédéric Boyer | |||
| Patricia Balard | |||
| P2860 | cites work | Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages | Q24310677 |
| Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice | Q24623151 | ||
| Atherosclerosis | Q24644573 | ||
| Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells | Q73954435 | ||
| Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice | Q74171931 | ||
| Effect of pepsin digestion on the antivenom activity of equine immunoglobulins | Q81422619 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets | Q28140238 | ||
| Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages | Q28210495 | ||
| Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade | Q28211233 | ||
| Nrf2-Keap1 defines a physiologically important stress response mechanism | Q28291002 | ||
| Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells | Q28378178 | ||
| Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase | Q28587071 | ||
| PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines | Q29620217 | ||
| Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor | Q33335777 | ||
| A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling' | Q33890754 | ||
| Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice | Q33905765 | ||
| Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages | Q33941623 | ||
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 | ||
| CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism | Q34372078 | ||
| Macrophage signaling and respiratory burst | Q34981891 | ||
| Pathophysiology of Human Genetic CD36 Deficiency | Q35122021 | ||
| Inflammatory and thrombotic mechanisms in coronary atherosclerosis | Q35201247 | ||
| Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress | Q35746990 | ||
| Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects | Q35764461 | ||
| Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system | Q35902539 | ||
| Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention | Q36101597 | ||
| Clinical pharmacokinetics of TNF antagonists: how do they differ? | Q36106353 | ||
| Rheumatoid arthritis: a disease associated with accelerated atherogenesis | Q36220303 | ||
| Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. | Q39563966 | ||
| Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. | Q40342289 | ||
| Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells | Q40610380 | ||
| Functional coupling of FcgammaRI to nicotinamide adenine dinucleotide phosphate (reduced form) oxidative burst and immune complex trafficking requires the activation of phospholipase D1. | Q40766971 | ||
| TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages | Q40889047 | ||
| Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis | Q43049221 | ||
| Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase | Q43912961 | ||
| Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 | ||
| Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression | Q44707909 | ||
| Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. | Q44748792 | ||
| Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation | Q44810026 | ||
| Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 | ||
| Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice | Q45042448 | ||
| Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha | Q45247247 | ||
| Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. | Q46483065 | ||
| High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. | Q52525441 | ||
| CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. | Q64986567 | ||
| Cross-linking of the high affinity Fc receptor for human immunoglobulin G1 triggers transient activation of NADPH oxidase activity. Continuous oxidase activation requires continuous de novo receptor cross-linking | Q69353939 | ||
| Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation | Q71087721 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adalimumab | Q348260 |
| P304 | page(s) | R22 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes | |
| P478 | volume | 9 |
| Q36639236 | Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling |
| Q24633702 | CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues |
| Q42801338 | Correlation between TSP-1, TGF-β and PPAR-γ expression levels and glioma microvascular density |
| Q39247208 | Gene expression profiling of macrophages: implications for an immunosuppressive effect of dissolucytotic gold ions |
| Q35140300 | HIV-1 Nef impairs key functional activities in human macrophages through CD36 downregulation |
| Q39214664 | Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation |
| Q37446773 | Hypoxia up-regulates CD36 expression and function via hypoxia-inducible factor-1- and phosphatidylinositol 3-kinase-dependent mechanisms |
| Q45978454 | Influence of pregnancy on the adipocytokine and peroxisome proliferator-activated receptor pathways in peripheral blood mononuclear cells from healthy donors and rheumatoid arthritis patients. |
| Q39977001 | LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPARγ ligand synthesis |
| Q33805096 | Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population. |
| Q40043141 | Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways |
| Q39246963 | Macrophage heterogeneity and cholesterol homeostasis: classically-activated macrophages are associated with reduced cholesterol accumulation following treatment with oxidized LDL. |
| Q34031187 | Nrf2, a PPARγ alternative pathway to promote CD36 expression on inflammatory macrophages: implication for malaria |
| Q42078784 | Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy |
| Q34780834 | Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis |
| Q28588228 | Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis |
| Q35105275 | Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic density |
| Q38064420 | Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. |
Search more.